Đo lường tuần hoàn các tham số miễn dịch không đặc hiệu ở bệnh nhân suy thận mãn tính đang chạy thận nhân tạo

Kerman RH, Geis WP: Total and active T-cell dynamics in renal allograft recipients. Surgery 79:398–407, 1976 Kerman RH, Geis WP: T-RFC monitoring of CMI events in renal allograft recipients. Transplant Proc 10:633–635, 1978 Kerman RH, Floyd M, Conner W, McConnell R, McConnell BJ, Van Buren CT, Kahan BD: Combined immunologic and radionuclide techniques to monitor renal allograft rejection. Transplant Proc 11:1229–1231, 1979 Steel CM, Evans J, Smith MA: Physiological variation in circulating B cell: T cell ratio in man. Nature 247:387–389, 1974 Carter JB, Barr GD, Levin AS, Byers VS, Ponce B, Fudenberg HH, German DF: Standardization of tissue culture conditions for spontaneous thymidine incorporation by unstimulated normal human peripheral lymphocytes: Circadian rhythm of DNA synthesis. J Allergy Clin Immunol 56:191–205, 1975 Dimitriu A, Debray-Sachs M, Descamps B, Sultan C, Hamburger J: Triated thymidine incorporation in blood leucocytes of renal allograft recipients. Transplant Proc 3:1577–1583, 1971 Kerman RH, Floyd M, Van Buren CT, Kahan BD: Correlation of non-specific immune monitoring with rejection or impaired function of renal allografts. Transplantation (in press), 1981 Kahan BD: Transplantation of organs.In Lewis Practice of Surgery, H. Goldsmith (ed). Hagerstown, MA, Harper and Row, 1978, pp 1077–1107 Kerman RH, Kahan BD: Clinical histocompatibility testing in renal transplantation: Potential keys to alloimmune specificity and reactivity.In Current Trends in Histocompatibility, R Reisfeld, S Ferrone (eds). New York, Plenum Press, 1980 Wybran J, Fudenberg HH: Thymus-derived rosette-forming cells. N Engl J Med 288:1072–1073, 1972 Fudenberg HH, Wybran J, Robbins D: T-rosette forming cells, cellular immunity and cancer. N Engl J Med 292:475–476 1975 Felsburg PJ, Edelman R, Gilman RH: The active E rosette test: Correlation with delayed cutaneous hypersensitivity. J Immunol 116:1110–1113, 1976 Casiani CU, DeSimone C, Bonini S, Gallucci MT, Matteucci G, Valesini G, Meli D, Masala C: Immunologic aspects of chronic uremia. Kidney Int 13(S):49–54, 1978 Wilson WE, Kirkpatrick CH, Talmadge DW: Suppression of immunologic responsiveness in uremia. Ann Intern Med 62:1–14, 1965 Kerman RH, Ing TS, Hano JE, Geis WP: Prognostic significance of the active thymus-derived rosette-forming cells in renal allograft survival. Surgery 82:607–612, 1977 Huber H, Pasternack D, Dittrich P, Braunsteiner H: In vitro reactivity of human lymphocytes in uremia: A comparison with the impairment of delayed hypersensitivity. Clin Exp Immunol 5:75–82, 1969 Sengar DPS, Hyslop DP, Rashid A, Harris JE: T-rosettes in hemodialysis patients and renal allograft recipients. Cell Immunol 20:92–97, 1975 Uittenbogaart CH, Robinson B, Malekzadeh H, Pennisi AJ, Ettenger RB, Fine RN: Pretransplant T-cell levels and renal allograft survival. Surgery 87:432–435, 1980 Sengar DPS, Rashid A, Harris JE: Post-transplant monitoring of renal allograft recipients for T, B and null lymphocyte subpopulations. Clin Exp Immunol 28:123–129, 1977 Hoy WE, Cestero RVM, Freeman RB: Lymphocyte subpopulations in maintenance hemodialysis patients. J Dialysis 2:1–15, 1978 Kelly GE, Sheil AGR: E-rosette forming cell numbers in the blood of human renal allograft recipients. Clin Exp Immunol 27:454–463, 1977 Touraine JL, Touraine F, Revillard JP, Brochier J, Traeger J: T-lymphocytes and serum inhibitors of cell mediated immunity in renal insufficiency. Nephron 14:195–208, 1975 Thomson SP, Rose JB, McMahon LJ: Stability of peripheral blood lymphocyte count and E-rosette forming lymphocytes in healthy adults. Immunol Comm 8:313–323, 1979 Wybran J, Carr MD, Fudenberg HH: Effect of serum on human rosette-forming cells in fetuses and adult blood. Clin Immunol Immunopathol 1:408–413, 1973 Smith R, Kerman R, Ezdinli E, Stefani S: A modified assay for the detection of human adult active rosette forming lymphocytes. J Immunol Methods 8:175–184, 1975 Tennenbaum JI, Pierre RL, Cerilli GJ: Evaluation of immunosuppressive therapy and clinical course in renal transplants in in vitro lymphocyte transformation. Transplantation 6:986–990, 1968 Hersh EM, Butler WT, Rossen RO, Suki W: In vitro studies of the human response to organ allografts: Appearance and detection of circulating activation lymphocytes. J Immunol 107:571–578, 1971 Pierce GE, Thomas JH, Vessela RL, Hermreck AS, Barth RF: Corticosteroids and leucocyte blastogensis in renal transplantation. Transplant Proc 11:364–369, 1979 Hamburger J, Debray-Sachs M, Dimitriu A, Lacombe M, Dimitriu D, deGrouchy J: Lymphocyte activation in allograft recipients. Transplant Proc 4:189–193, 1972 Bishop G, Cosimi AB, Voynow NK, Whelchel JD, Wortis HS: Effect of immunosuppressive therapy for renal allograft on the number of circulating sheep red blood cell rosetting cells. Transplantation 20:123–129, 1975 Lopez C, Simmons RL, Touraine JL, Park BH, Good RA: Discrepancy between PHA responsiveness and quantitative estimates of T-cell numbers in human peripheral blood during chronic renal failure and immunosuppression after transplantation. Clin Immunol Immunopathol 4:135–142, 1975 Tursz T, Fourneir C, Kreis H, Crosnier J, Bach JF: T-lymphocytes in kidney allograft recipients. Br Med J 1:799–807, 1976